Acro Biomedical Co's total assets for Q2 2025 were $53.28K, an increase of 111.63% from the previous quarter. ACBM total liabilities were $370.80K for the fiscal quarter, a 12.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.